Based on research in post-surgery patients, the FDA approved suzetrigine, a non-opioid analgesic, for the treatment of adults with moderate to severe acute pain.
The FDA accepted a new drug application for suzetrigine, a non-opioid analgesic, based on the results from clinical trials in patients with neuropathy and those post-surgery.